UnitedHealth Group Incorporated $UNH Shares Sold by Berbice Capital Management LLC

Berbice Capital Management LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 71.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,630 shares of the healthcare conglomerate’s stock after selling 4,000 shares during the quarter. UnitedHealth Group comprises about 0.4% of Berbice Capital Management LLC’s investment portfolio, making the stock its 29th biggest position. Berbice Capital Management LLC’s holdings in UnitedHealth Group were worth $509,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Hemington Wealth Management increased its position in UnitedHealth Group by 2.5% during the 1st quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock worth $604,000 after purchasing an additional 28 shares in the last quarter. Tlwm increased its position in shares of UnitedHealth Group by 1.0% in the first quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock worth $1,433,000 after acquiring an additional 28 shares in the last quarter. Endowment Wealth Management Inc. lifted its holdings in shares of UnitedHealth Group by 5.0% during the 1st quarter. Endowment Wealth Management Inc. now owns 650 shares of the healthcare conglomerate’s stock valued at $341,000 after acquiring an additional 31 shares in the last quarter. Alesco Advisors LLC increased its holdings in UnitedHealth Group by 6.2% in the 1st quarter. Alesco Advisors LLC now owns 562 shares of the healthcare conglomerate’s stock valued at $294,000 after purchasing an additional 33 shares in the last quarter. Finally, Forefront Analytics LLC lifted its stake in shares of UnitedHealth Group by 4.2% during the first quarter. Forefront Analytics LLC now owns 820 shares of the healthcare conglomerate’s stock worth $430,000 after purchasing an additional 33 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

UNH has been the topic of several recent research reports. Royal Bank Of Canada boosted their price target on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Mizuho boosted their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Bank of America raised their price target on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a report on Wednesday, October 8th. JPMorgan Chase & Co. raised their target price on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Finally, Morgan Stanley boosted their price target on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. Eighteen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $397.12.

UnitedHealth Group Price Performance

Shares of UNH opened at $324.72 on Wednesday. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a market cap of $294.14 billion, a price-to-earnings ratio of 16.95, a PEG ratio of 2.28 and a beta of 0.43. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $622.83. The stock has a 50 day moving average of $342.54 and a 200-day moving average of $315.53.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. During the same quarter in the previous year, the company posted $7.15 earnings per share. The firm’s revenue was up 12.2% on a year-over-year basis. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s payout ratio is presently 46.14%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.